Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Mao

Showing results (541-550 of 618) with videos related to

Pageof 62
Sort By:
Oncoimmunology|January 31, 2022
Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastomaKaidi Yang, Yu Shi, Min Luo, et al.
Scientific Reports|January 18, 2020
Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinaseNan-Nan Zhang, Jin-Sen Kang, Shuai-Shuai Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2019
Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic DegradationJing Xu, Hongsheng Wang, Yi Hu, et al.
Aging|September 29, 2020
Distant metastasis prediction via a multi-feature fusion model in breast cancerWenjuan Ma, Xin Wang, Guijun Xu, et al.
Biology|November 27, 2025
Infants Receive More Care by Harassing Matings in a Multi-Level Primate SocietyFang-Jun Cao, James R Anderson, Wei-Wei Fu, et al.
Nature Communications|February 25, 2026
Responsive interlayer spacing in staggered metal-organic framework nanosheet membranesXiaoyan Peng, Liwei Han, Xuanhao Wu, et al.
American Journal of Cancer Research|June 12, 2018
ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cellsKang Song, Ye Yuan, Yong Lin, et al.
Frontiers in Endocrinology|August 29, 2022
Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosisXiaoning Wang, Xin Zhang, Yidan Han, et al.
International Journal of Cancer|February 6, 2019
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcomaGangyang Wang, Mengxiong Sun, Yafei Jiang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 8, 2011
[General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease]Min-de Zeng, Bing-yuan Wang, Cheng-wei Chen, et al.
Pageof 62

Showing results (541-550 of 618) with videos related to

Sort By:
Pageof 62
Oncoimmunology|January 31, 2022
Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastomaKaidi Yang, Yu Shi, Min Luo, et al.
Scientific Reports|January 18, 2020
Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinaseNan-Nan Zhang, Jin-Sen Kang, Shuai-Shuai Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2019
Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic DegradationJing Xu, Hongsheng Wang, Yi Hu, et al.
Aging|September 29, 2020
Distant metastasis prediction via a multi-feature fusion model in breast cancerWenjuan Ma, Xin Wang, Guijun Xu, et al.
Biology|November 27, 2025
Infants Receive More Care by Harassing Matings in a Multi-Level Primate SocietyFang-Jun Cao, James R Anderson, Wei-Wei Fu, et al.
Nature Communications|February 25, 2026
Responsive interlayer spacing in staggered metal-organic framework nanosheet membranesXiaoyan Peng, Liwei Han, Xuanhao Wu, et al.
American Journal of Cancer Research|June 12, 2018
ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cellsKang Song, Ye Yuan, Yong Lin, et al.
Frontiers in Endocrinology|August 29, 2022
Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosisXiaoning Wang, Xin Zhang, Yidan Han, et al.
International Journal of Cancer|February 6, 2019
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcomaGangyang Wang, Mengxiong Sun, Yafei Jiang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 8, 2011
[General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease]Min-de Zeng, Bing-yuan Wang, Cheng-wei Chen, et al.
Pageof 62